Remdesivir Recruiting Phase 3 Trials for Remdesivir / Novel Coronavirus Infectious Disease (COVID-19) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04257656Severe 2019-nCoV Remdesivir RCT